Cengild Medical Berhad (KLSE:CENGILD)
0.270
0.00 (0.00%)
At close: Feb 21, 2025
Cengild Medical Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2018 |
Market Capitalization | 225 | 262 | 329 | 328 | - | - | Upgrade
|
Market Cap Growth | -17.91% | -20.25% | 0.45% | - | - | - | Upgrade
|
Enterprise Value | 163 | 188 | 255 | 331 | - | - | Upgrade
|
Last Close Price | 0.27 | 0.30 | 0.37 | 0.37 | - | - | Upgrade
|
PE Ratio | 19.57 | 23.68 | 24.76 | 34.88 | - | - | Upgrade
|
Forward PE | - | 23.00 | 23.00 | 24.24 | - | - | Upgrade
|
PS Ratio | 2.97 | 3.92 | 4.68 | 5.08 | - | - | Upgrade
|
PB Ratio | 1.95 | 2.36 | 3.10 | 3.52 | - | - | Upgrade
|
P/TBV Ratio | 1.99 | 2.36 | 3.10 | 3.52 | - | - | Upgrade
|
P/FCF Ratio | - | - | 27.92 | 21.98 | - | - | Upgrade
|
P/OCF Ratio | 10.19 | 20.28 | 23.65 | 21.37 | - | - | Upgrade
|
PEG Ratio | 0.64 | 0.64 | 0.64 | 0.67 | - | - | Upgrade
|
EV/Sales Ratio | 2.15 | 2.81 | 3.62 | 5.14 | - | - | Upgrade
|
EV/EBITDA Ratio | 8.86 | 12.64 | 15.59 | 22.72 | - | - | Upgrade
|
EV/EBIT Ratio | 12.73 | 15.25 | 17.60 | 28.61 | - | - | Upgrade
|
EV/FCF Ratio | -6.31 | - | 21.60 | 22.21 | - | - | Upgrade
|
Debt / Equity Ratio | 0.28 | 0.07 | 0.14 | 0.17 | 1.75 | 2.95 | Upgrade
|
Debt / EBITDA Ratio | 1.76 | 0.50 | 0.85 | 1.01 | 1.25 | 2.47 | Upgrade
|
Debt / FCF Ratio | - | - | 1.27 | 1.09 | 1.92 | 2.72 | Upgrade
|
Asset Turnover | 0.49 | 0.51 | 0.56 | 0.78 | 1.36 | 0.84 | Upgrade
|
Inventory Turnover | 20.02 | 23.10 | 31.23 | 36.62 | 42.83 | 26.16 | Upgrade
|
Quick Ratio | 3.75 | 6.59 | 9.17 | 7.91 | 1.06 | 0.74 | Upgrade
|
Current Ratio | 3.82 | 6.73 | 9.32 | 8.04 | 1.16 | 0.81 | Upgrade
|
Return on Equity (ROE) | 10.23% | 10.19% | 13.35% | 17.60% | 84.90% | 50.59% | Upgrade
|
Return on Assets (ROA) | 5.21% | 5.84% | 7.19% | 8.74% | 19.43% | 9.43% | Upgrade
|
Return on Capital (ROIC) | 5.97% | 6.41% | 7.85% | 9.83% | 23.59% | 11.23% | Upgrade
|
Return on Capital Employed (ROCE) | 8.90% | 10.48% | 12.02% | 10.72% | 41.30% | 20.67% | Upgrade
|
Earnings Yield | 5.11% | 4.22% | 4.04% | 2.87% | - | - | Upgrade
|
FCF Yield | -11.47% | -1.07% | 3.58% | 4.55% | - | - | Upgrade
|
Dividend Yield | 4.44% | 2.43% | 1.98% | 0.99% | - | - | Upgrade
|
Payout Ratio | 53.59% | 55.64% | 45.60% | - | 72.81% | - | Upgrade
|
Buyback Yield / Dilution | -0.33% | -1.00% | -27.94% | -7.56% | -4700.00% | - | Upgrade
|
Total Shareholder Return | 4.12% | 1.44% | -25.96% | -6.56% | -4700.00% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.